SCHEMBL763190

SCHEMBL763190

CC(C)(C)OC(=O)N[C@@H](CC(=O)N1CCC[C@@H](c2nc3ccccc3[nH]2)C1)Cc1ccc(-c2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HTR2B P41595 6/20 0.47
PTPN1 P18031 1/20 0.46
POLB P06746 2/20 0.46
KDM4E B2RXH2 3/20 0.46
PRCP P42785 2/20 0.45
MAPK1 P28482 1/20 0.45
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ITGB3 P05106 1/20 0.42
ITGAV P06756 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL763367 0.92 GRIN2B (0.49) PTPN1POLBKDM4EMAPK1CYP1A2
SCHEMBL763468 0.92 GRIN2B (0.49) PTPN1POLBKDM4EMAPK1CYP1A2
SCHEMBL762472 0.92 POLB (0.46) PTPN1POLBKDM4EMAPK1CYP1A2
SCHEMBL762470 0.92 GRIN2B (0.49) PTPN1POLBKDM4EMAPK1CYP1A2
SCHEMBL743205 0.89 HTR2B (0.53) HTR2BPOLBKDM4EMAPK1CYP1A2
SCHEMBL762864 0.83 MAPK1 (0.45) POLBKDM4EMAPK1CYP1A2CYP3A4
SCHEMBL762586 0.83 CYP1A2 (0.42) POLBKDM4EPRCPMAPK1CYP1A2
SCHEMBL742133 0.82 KDM4E (0.50) HTR2BPOLBKDM4EMAPK1CYP1A2
SCHEMBL740995 0.82 GRIN2B (0.54) HTR2BPOLBKDM4EMAPK1CYP1A2
SCHEMBL740091 0.81 HTR2B (0.56) HTR2BPOLBKDM4EMAPK1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138168-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-20 US disclosed
US-8138168-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-20 US disclosed